Roma people constitute one of the oldest and largest minorities in Europe. In Slovakia, there are approximately 400,000 Roma, and represent 7.5% of total population (1). However, according to recent official census in 2010, only 105,738 (2% of total population) citizens declared themselves as Roma ethnic. Approximately one sixth of Roma people live in segregated settlements (1). This supplement contains results of the HepaMeta study, which has aimed to map the socioeconomic, lifestyle, selected anthropometric, and health-related aspects of young Roma people living in the settlements and their majority counterparts. This study was conducted in 2011 and its main goal was to explore the prevalence of hepatitis B and C and metabolic syndrome. A group of 452 Roma aged 18-55 years, living in settlements (mean age = 34.7; 35.2% men) was compared to a control group of 403 non-Roma randomly chosen (mean age = 33.5; 45.9% men) from the patient database of collaborating general practitioners. Data were obtained by questionnaire, anthropometric measures and analysed blood and urine samples (2).
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asymptomatic chronic hepatitis as well as in liver cirrhosis. These diseases have very high mortality and their treatment is economically demanding as well (14) . Vaccination against hepatitis B has been known since 1971, but in Slovakia it has been routinely applied in newborns only since 1998 (15, 16) . Vaccination generally significantly reduces incidence and prevalence of hepatitis B and its complications (liver cirrhosis and hepatocellular carcinoma). Authors have included participants who were not routinely vaccinated against hepatitis B. In view of very high reported prevalence of hepatitis B in Roma population in segregated settlements, routine vaccination of Roma people without serological markers of hepatitis B should be considered.
Metabolic syndrome was diagnosed in 29.2% of Roma population, but only in 20.7% of the majority population (17) . Dyslipidemia with decreased levels of HDL cholesterol was also more prevalent in the Roma population compared to the majority (18) . Obese Roma people had larger waist circumference, hip circumference, waist to hip ratio, lower levels of HDL cholesterol, adiponectin, and higher levels of triacylglyceroles. Furthermore, inflammatory parameters (CRP and TNF alpha) were elevated in this population (19) . Prevalence of metabolic syndrome increases with age. In the study population men and women aged 40 and above had multiple times higher risk of metabolic syndrome compared to the age group 18-39 years. In the Roma population metabolic syndrome significantly increases cardiovascular risk (20) . Severe complications of coronary heart disease were detected in Roma population at significantly younger age compared to the majority population. Roma people who had undergone coronarography were on average 5 years younger than the majority population (52 vs. 57). They suffered from significant coronary stenosis and multiple stenosis requiring bypass surgery as well as from myocardial infarction more frequently than members of the majority population (60% vs. 44%). This is in line with the reported data on more frequent and more severe metabolic syndrome as well as reduced statins use compared to the majority population (21) .
Patients with metabolic syndrome have increased risk not only of coronary heart disease, but non-alcoholic fatty liver disease as well. Authors report that Roma people (abstaining from alcohol) with elevated activity of serum gamma-glutamyl transpeptidase (GGT) had significantly more often metabolic syndrome, but also more often fulfilled individual criteria of metabolic syndrome with the exception of decreased HDL cholesterol. In these patients authors also report elevated levels of inflammatory proteins (ferritin and hs-CRP) compared to Roma people with normal levels of GGT. Nonalcoholic fatty liver disease is another disease that was found to be very prevalent in Roma population, and these patients have increased risk of liver and cardiovascular morbidity (22) .
Besides hepatitis B, other sexually transmitted diseases could be expected in Roma population. Results from the presented HepaMeta study report showed trend towards higher prevalence of Chlamydia trachomatis infection in the Roma population compared to the age adjusted majority population (23) . In the view of previously presented data on barriers in accessing healthcare and on socioeconomic conditions and lifestyle among the Roma population in settlements, higher prevalence of other diseases could be expected. Authors report higher prevalence of kidney diseases in Roma women compared to the majority. In fact, all 6 young persons with significant proteinuria were Roma women. Roma women compared to the age adjusted majority women group had significantly lower glomerular filtration rate. In total, Roma women had 56% higher risk of chronic kidney diseases than their majority counterparts (24) . Authors also describe more frequent proteinuria associated with elevated levels of total cholesterol in Roma men and women in settlements, compared to the majority (18) . Higher prevalence of proteinuria and reduced glomerular filtration rate in younger age predict higher risk of end-stage renal disease later on. Koľvek et al. found out that Roma people have 2.85 times higher relative risk of developing end-stage renal disease compared to the age adjusted majority. Roma people constitute 11.6% of dialyzed patients in Slovakia. They are on average 10 years younger and have more often diabetic nephropathy at time of the first hemodialysis compared to the majority population (25) .
Authors and contributors of the HepaMeta study have extensively mapped the socioeconomic conditions, lifestyle and morbidity of the younger Roma population living in segregated settlements in the eastern Slovakia. Although poor living conditions and lifestyle, unemployment and poverty were expected, authors report an alarming prevalence of severe diseases, specifically chronic viral hepatitis B, nonalcoholic fatty liver disease, metabolic syndrome, and kidney disease. Therefore, it is not a big surprise that life expectancy of Roma men and Roma women compared to the majority is 7.5 years and 6.6 years lower, respectively (26) . Roma minority is a big challenge from the viewpoint of social inclusion and integration policies -as both called for by international organizations and committed to by state authorities. The segregation in the communities creates sense of powerlessness and hopelessness among Roma people on one hand and lot of effort to improve their socioeconomic conditions by competent national and local bodies on the other. Providing adequate education and employment is surely one of the best sustainable ways to reduce poverty and improve the socioeconomic status of Roma people, but vast majority of attempts whether national or international have brought only a little improvement. It is absolutely necessary to put in place such mechanisms and instruments that maximally shorten the way "from intended help to its recipient". It is important to decrease distrust, apathy and reliance on welfare of Roma people in these settlements as well as suspicion, antipathy and discriminatory approaches on the side of majority.
Taking into account the current living conditions of Roma it is advisable to implement some immediate health protection and health care measures that can go beyond the scope of generally provided health benefits. Recalling the outcomes of this study, the vaccination of all Roma people in the settlements against hepatitis B is a priority. It could prevent the chronic hepatitis B and its late stage complications, which will in the long run save a lot of money needed to treat these patients later on. The decreased morbidity and increased life expectancy can be expected after implementing a whole range of interventions including the change of socioeconomic conditions and health awareness of Roma people living in segregated communities. Only through a whole-of-society approach promoting equity in health ensuring access to good quality health services and providing community assistance in care for health it will be possible to get rid of the negative legacy associated with the desperate life of Roma minority in Slovakia.
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